Press Research

Landmark Publication Points to IC14 Target in ALS-MND

ALS-MND is our leading clinical program in neurodegeneration; however Parkinson’s and Alzheimer’s disease are also coming into sharp focus with some extraordinary new data directly related to IC14. This new publication of a landmark paper in the prestigious Nature family of journals by our close collaborators at Houston Methodist Neurological Institute, led by our colleague and friend, […]

Press Research sCD14

New research links IC14 target to dementia

New research published in the world’s leading journal Neurology reports a link between higher levels of an inflammatory marker called sCD14 and a higher risk of developing dementia.  The study looked at blood samples and dementia diagnosis of more than 4,700 people over a decade. Researchers found that people with higher blood levels of sCD14 […]